# EDGAR Filing Document

**Accession Number:** 0000926617
**File Stem:** 0001104659-25-114080
**Filing Date:** 2025-11
**Character Count:** 2534
**Document Hash:** 70c7588fe4fd0420339a5c7521b4ffb7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-114080.hdr.sgml**: 20260327

**ACCESSION NUMBER**: 0001104659-25-114080

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aspira Women's Health Inc.
- **CENTRAL INDEX KEY:** 0000926617
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 330595156
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 12117 BEE CAVES ROAD BUILDING THREE
- **STREET 2:** SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
- **BUSINESS PHONE:** 512-519-0400

**MAIL ADDRESS:**
- **STREET 1:** 12117 BEE CAVES ROAD BUILDING THREE
- **STREET 2:** SUITE 100
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VERMILLION, INC.
- **DATE OF NAME CHANGE:** 20070824

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CIPHERGEN BIOSYSTEMS INC
- **DATE OF NAME CHANGE:** 20000316

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ABIOTIC SYSTEMS
- **DATE OF NAME CHANGE:** 19950407

November 19, 2025

**VIA EDGAR TRANSMISSION**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: Daniel Crawford

Re: Aspira Women's Health Inc. <br> Registration Statement on Form S-1 <br> Filed October 20, 2025 (File No. 333-290633)

Dear Mr. Crawford,

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective on November 21, 2025, at 4:00 p.m., Eastern Time, or as soon as thereafter as practicable, or at such later time as Aspira Women's Health Inc. (the "<u>Company</u>") or its counsel may request via telephone call to the Staff. Please contact J. Eric Johnson of Winston & Strawn LLP, counsel to the Company, at (713) 651-2647 to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.

---

| | |
|:---|:---|
| Sincerely yours, | Sincerely yours, |
| Aspira Women's Health Inc. | Aspira Women's Health Inc. |
| By: | /s/ Mike Buhle |
| Name: | Mike Buhle |
| Title: | Chief Executive Officer |

---

cc: J. Eric Johnson, Esq.

------